Valuation: QuidelOrtho Corporation

Market Cap 1.14B 992M 925M 851M 1.6B 109B 1.64B 10.95B 4.29B 53.86B 4.27B 4.18B 186B P/E 2026 *
-10.4x
P/E 2027 * -104x
Enterprise Value 3.51B 3.06B 2.85B 2.62B 4.92B 335B 5.05B 33.77B 13.22B 166B 13.16B 12.88B 573B EV / Sales 2026 *
1.29x
EV / Sales 2027 * 1.23x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day-1.02%
1 week+0.43%
Current month-5.80%
1 month+19.65%
3 months+37.27%
6 months-38.41%
Current year-42.23%
1 week 16
Extreme 16
17.51
1 month 15.49
Extreme 15.49
19.17
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
88.14
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Director/Board Member 73 2013-12-31
Director/Board Member 62 2024-12-05
Director/Board Member 61 2024-05-14
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%+0.43%-36.76%-81.06% 1.14B
+1.44%+3.87%+17.53%-38.48% 15.69B
+0.63%+10.05%+0.58%+99.42% 1.74B
+0.88%-1.57%-37.79%+14.13% 976M
+2.34%+2.73%-44.06%-53.05% 633M
+1.73%+1.89%-46.79%-56.39% 517M
-1.62%+2.15%+38.61%-52.49% 470M
+2.26%+1.93%-55.19%-60.00% 376M
+5.68%+5.39%-15.50%-31.11% 355M
-6.20%-18.06%+24.21% - 289M
Average +0.61%-1.03%-15.52%-28.78% 2.22B
Weighted average by Cap. +1.18%+1.48%+6.50%-28.75%

Financials

2026 *2027 *
Net sales 2.71B 2.36B 2.2B 2.03B 3.81B 259B 3.9B 26.11B 10.22B 128B 10.17B 9.95B 443B 2.8B 2.44B 2.28B 2.1B 3.93B 268B 4.03B 26.96B 10.56B 133B 10.51B 10.28B 457B
Net income -156M -136M -127M -117M -219M -14.9B -224M -1.5B -588M -7.38B -585M -572M -25.46B -81.93M -71.49M -66.65M -61.33M -115M -7.84B -118M -789M -309M -3.88B -308M -301M -13.38B
Net Debt 2.37B 2.07B 1.93B 1.77B 3.33B 227B 3.41B 22.82B 8.93B 112B 8.89B 8.7B 387B 2.3B 2.01B 1.87B 1.72B 3.23B 220B 3.31B 22.14B 8.67B 109B 8.63B 8.44B 376B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-29 US$16.49 -1.08% 1,187,973
26-07-28 US$16.67 -0.95% 989,723
26-07-27 US$16.83 +4.86% 1,057,029
26-07-24 US$16.05 -3.20% 913,043
26-07-23 US$16.58 -0.60% 806,537
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
16.49USD
Average target price
20.50USD
Spread / Average Target
+24.32%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock